Fotmer Life Sciences is a cannabis cultivator and extractor and one of the world’s largest Good Agricultural and Collection Practice (GACP), Uruguayan-GMP and European Union-GMP (EU GMP) certified global cannabis exporters. With strategic assets established in Uruguay, the first country to federally legalize cannabis, and strong relationships across the United States, the European Union and Middle East, Fotmer is well positioned to dominate the global cannabis cultivation market through its low-cost production capacity and established international transportation infrastructure.
| Website | http://www.fotmer.com |
| Revenue | $8.7 million |
| Employees | 54 (32 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Cannabis Cultivation, Cannabis Extraction, Cannabis Production, Cannabis Processing, Good Manufacturing Practices, Cannabis Extracts, Global Cannabis Market, Agricultural Practices, Cannabis Concentrates, Pharmaceutical Cannabis, Medical Cannabis, Hemp Cultivation, Hemp Processing, Natural Remedies, Plant-Based Medicine |
| Competitors | Johnson & Johnson, Roche, Novartis, Merck & Co., Inc., Pfizer, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences, Biogen +50 more (view full list) |
Looking for a particular Fotmer Life Sciences employee's phone or email?
The Fotmer Life Sciences annual revenue was $8.7 million in 2026.
Javier Varela Ubillos is the COO of Fotmer Life Sciences.
32 people are employed at Fotmer Life Sciences.